Stay updated on Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Sign up to get notified when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-30T18:55:58.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page has undergone significant updates, including the removal of detailed information about cutaneous squamous cell carcinoma (cSCC) and the addition of new collaborators and a revision note. The core content related to cSCC treatment and prognosis has been largely deleted, which may impact the comprehensiveness of the information provided.
    Difference
    62%
    Check dated 2025-04-16T13:23:23.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.0%
    Check dated 2025-04-09T06:54:42.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.0%
    Check dated 2025-04-01T22:59:31.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T20:18:34.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The webpage now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-10T09:34:07.000Z thumbnail image

Stay in the know with updates to Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunotherapy +/- EGFR Inhibitor in Advanced cSCC Clinical Trial page.